Global Shrimps Disease Diagnostics Market Size By Type (Fundamental Analysis, Rapid Testing), By Application (Fisheries, Marine Laboratories), By Region, And Segment Forecasts, 2023 to 2032

lobal Shrimps Disease Diagnostics Market Report Description

The Global Shrimps Disease Diagnostics Market was valued at USD 520 million in 2023 and is projected to surpass USD 930 million by 2031, growing at a CAGR of 7.4% during the forecast period (2023-2031).

The increasing prevalence of shrimp diseases such as White Spot Syndrome Virus (WSSV), Acute Hepatopancreatic Necrosis Disease (AHPND), and Enterocytozoon hepatopenaei (EHP) is driving the demand for accurate and rapid diagnostics. The rise in global shrimp farming, coupled with the growing seafood trade, emphasizes the need for efficient disease management to prevent economic losses. Advancements in molecular diagnostic tools, growing awareness among shrimp farmers, and the rising adoption of biosecurity measures are further boosting market growth.

Drivers

✅ Increasing Disease Outbreaks in Shrimp Aquaculture

Frequent disease outbreaks in shrimp farms lead to massive economic losses, prompting farmers to adopt advanced diagnostic techniques for early detection and prevention.

✅ Technological Advancements in Aquatic Diagnostics

The introduction of PCR-based diagnostic kits, immunoassays, and portable diagnostic tools has enhanced the accuracy and speed of shrimp disease detection, driving adoption.

✅ Rising Global Demand for Shrimp

The booming seafood market and increasing consumer demand for healthy protein sources are pushing shrimp farmers to adopt disease diagnostics to ensure sustainable production.

Restraints

❌ High Cost of Advanced Diagnostic Tools

The high price of molecular diagnostic kits can limit adoption in small and medium-scale farms, particularly in developing countries.

❌ Lack of Skilled Personnel

The effective use of advanced diagnostics requires trained personnel, and the shortage of expertise in some regions hampers market growth.

Opportunities

💡 Expansion of Shrimp Farming in Emerging Economies

Countries in Asia-Pacific and Latin America are witnessing rapid shrimp farming growth, creating significant opportunities for diagnostics providers.

💡 Development of Rapid On-site Testing Solutions

Point-of-care diagnostic tools that provide quick results in farm environments are gaining traction, offering lucrative growth avenues for market players.

💡 Integration of AI and Digital Platforms

AI-powered disease prediction and digital farm monitoring systems can revolutionize shrimp health management and create new revenue streams for diagnostics companies.

Market by System Type Insights

Molecular Diagnostic Kits (PCR, qPCR) dominate the market in 2023 due to their high accuracy and sensitivity in detecting shrimp pathogens.

Immunological Assays (ELISA, lateral flow tests) are gaining traction for rapid, cost-effective field diagnostics.

Biosensors & Next-Generation Sequencing (NGS) are emerging as high-potential technologies for comprehensive disease detection.

Market by End-use Insights

Shrimp Farms are the largest end-users, accounting for over 55% market share in 2023, driven by the need for preventive disease management.

Aquatic Research Institutes and Diagnostic Laboratories also represent significant demand, especially for advanced molecular testing.

Market by Regional Insights

Asia-Pacific dominates the market, holding over 60% share in 2023, due to the concentration of shrimp farming in countries like China, India, Vietnam, and Thailand.

Latin America (Ecuador, Brazil, Mexico) is the fastest-growing region, supported by increasing shrimp production and export demand.

North America and Europe are driven by stringent seafood import regulations, boosting the need for disease-free shrimp certification.

Competitive Scenario

Key players in the Global Shrimps Disease Diagnostics Market include Thermo Fisher Scientific, GeneReach Biotechnology, Agdia, IQ2000 Diagnostics, Speedx Diagnostics, BioNote Inc., and AquaCHAMP Laboratories.

These companies focus on product innovation, rapid diagnostics, strategic collaborations, and geographic expansion.

In 2024, GeneReach Biotechnology launched a multi-pathogen shrimp diagnostic panel for simultaneous detection of major viral and bacterial infections.

In 2023, Thermo Fisher introduced a portable qPCR platform for on-site shrimp disease detection.

In 2025, Speedx Diagnostics partnered with a leading aquaculture group to deploy AI-driven disease prediction systems.

Scope of Work – Global Shrimps Disease Diagnostics Market

Key Market Developments

2024: GeneReach Biotechnology introduced a high-throughput shrimp virus detection kit covering multiple pathogens.

2023: Thermo Fisher Scientific launched a portable qPCR platform for shrimp farms, improving on-site diagnostics.

2025: Speedx Diagnostics announced the integration of AI and IoT-based disease monitoring systems for large-scale aquaculture operations.

FAQs

1️⃣ What is the current market size of the Global Shrimps Disease Diagnostics Market?

The market was valued at USD 520 million in 2023.

2️⃣ What is the major growth driver of the Global Shrimps Disease Diagnostics Market?

The primary driver is the increasing frequency of shrimp disease outbreaks and the rising need for rapid, accurate diagnostics.

3️⃣ Which is the largest region during the forecast period in the Global Shrimps Disease Diagnostics Market?

Asia-Pacific is the largest and most dominant region due to its extensive shrimp farming industry.

4️⃣ Which segment accounted for the largest market share in the Global Shrimps Disease Diagnostics Market?

Molecular diagnostic kits (PCR & qPCR) accounted for the largest share due to their accuracy and reliability.

5️⃣ Who are the key market players in the Global Shrimps Disease Diagnostics Market?

Key players include Thermo Fisher Scientific, GeneReach Biotechnology, Agdia, IQ2000 Diagnostics, and Speedx Diagnostics.

Would you like me to generate similar descriptions for multiple aquaculture-related diagnostic markets (e.g., fish disease diagnostics, shellfish diagnostics) in the same structured format? Or should I also create a ready-to-publish PDF version of this report?